carmustine has been researched along with mechlorethamine in 94 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 65 (69.15) | 18.7374 |
1990's | 18 (19.15) | 18.2507 |
2000's | 8 (8.51) | 29.6817 |
2010's | 3 (3.19) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
García-Mera, X; González-Díaz, H; Prado-Prado, FJ | 1 |
Hahn, GM | 1 |
Bakemeier, RF; Bennett, JM; Carbone, PP; Ezdinli, E; Lenhard, RE | 1 |
Adler, S; Han, T; Shimaoka, K; Tsukada, Y | 1 |
Bruntsch, U | 1 |
Maruyama, Y | 1 |
Ewig, RA; Kohn, KW | 2 |
Moore, JV | 3 |
Bank, A; Blom, J; Brunner, K; Coleman, M; Cornell, C; Cuttner, J; Falkson, G; Glidewell, O; Harley, JB; Haurani, F; Henry, P; Holland, JF; James, GW; Leone, L; Martz, G; Maurice, P; Nissen, NI; Pajak, TF; Pedersen-Bjergaard, J; Sawitsky, A; Seligman, B; Senn, HJ; Shapiro, L; Spurr, CL; Stutzman, L | 1 |
Epstein, EH; Grekin, DA; Zackheim, HS | 1 |
Bhuyan, BK; Day, KJ; Fraser, TJ; Loughman, BE | 1 |
Bergsagel, DE; Pruzanski, W | 1 |
Aungst, CW; Ezdinli, E; Kaufman, JH; Stutzman, L | 1 |
Bains, E; Jett, J; Maruyama, Y; Raju, MR | 1 |
Avadhani, NG; Hansel, J; Ritter, CA; Rutman, RJ | 1 |
Goldenberg, GJ | 1 |
Chan, YK; Dorfman, R; Durant, JR; Loeb, V | 1 |
Bleehen, NM; Twentyman, PR | 1 |
Epstein, EH; Zackheim, HS | 1 |
Avadhani, NG; Rutman, RJ | 1 |
Bosly, A; Doyen, C; Ferrant, A; Machiels, JP; Martiat, P; Michaux, JL | 1 |
Allalunis-Turner, MJ; Barron, GM; Day, RS; Dobler, K; Urtasun, RC | 1 |
Bastion, Y; Coiffier, B; Tigaud, JD | 1 |
Allalunis-Turner, MJ; Allen, PB; Aronyk, KE; Day, RS; Fulton, DS; Huyser-Wierenga, D; McKean, JD; Petruk, KC; Urtasun, RC; Weir, BK | 1 |
Barnett, MJ; Connors, JM; Fay, JW; Herzig, GP; Herzig, RH; Klingemann, HG; Phillips, GL; Reece, DE; Shepherd, JD; Wolff, SN | 1 |
Binon, J; Ferrant, A; Hamoir, V; Michaux, JL; Sokal, G | 1 |
Kunz, BA; Mis, JR | 1 |
Bodell, WJ; Doane-Setzer, P; Evans, CG; Smith, MT; Tokuda, K | 1 |
Fram, RJ; Marinus, MG; Sullivan, J | 1 |
Aida, T; Bodell, WJ | 2 |
Bernal, S; Cucchi, CA; Ervin, TJ; Frei, E; Haseltine, WA; Rosowsky, A; Ruprecht, RM; Tantravahi, R | 1 |
Micaily, B; Vonderheid, EC | 1 |
Carbone, PP | 1 |
Carter, SK; Goldsmith, MA | 1 |
Desser, RK; Ultmann, JE | 1 |
Stacher, A | 1 |
al-Mondhiry, H; Connolly, CE; Lacher, MJ; Sahakian, GJ | 1 |
McLaren, JH; Papac, RJ | 1 |
Carter, SK; Comis, RL | 1 |
Abelson, HT; Karlan, D; Penman, S | 1 |
Frei, E; Goldin, A; Schabel, FM | 1 |
Pruzanski, W; Saito, S | 1 |
Carter, SK; Livingston, RB | 1 |
Glidewell, OJ; Holland, JF; Nissen, NI; Stutzman, L | 1 |
Lenhard, RE | 1 |
Rubin, P | 1 |
DeVita, VT | 1 |
Merker, PC; Sapru, HN | 1 |
Fairley, GH | 1 |
Anderson, JR; Bakemeier, RF; Berard, CW; Costello, W; DeVita, VT; Glick, JH; Hines, JD; Horton, J; Rosner, G | 1 |
Arrick, BA; Nathan, CF | 1 |
Cornbleet, MA; Leonard, RC; Smyth, JF | 1 |
Ritter, C; Rutman, RJ | 1 |
Bartolucci, AA; Durant, JR; Gams, RA; Liu, C | 1 |
Dantas, ME; Glode, LM; Koeppler, H; Morton, N; Robinson, WA; Sutherland, J; Thomas, MR | 1 |
Zackheim, HS | 3 |
Dieckman, J; Medoff, G; Valeriote, F | 1 |
Bakemeier, RF; Barnes, JM; Bennett, JM; Costello, W; Glick, JH; Neiman, RS; Orlow, EL; Prosnitz, LR | 1 |
Benckhuysen, C; van der Steen, J; van Wichen, BH | 1 |
Aggarwal, KK; Gomez, GA; Han, T | 1 |
Iyengar, CL; Ritter, C; Rutman, RJ | 1 |
Bicher, HI; Brown, M; Hetzel, FW; Kaufman, N | 1 |
Smuckler, EA; Zackheim, HS | 1 |
Chase, ES; Shafer, RH | 1 |
Lin, HS | 1 |
Twentyman, PR | 1 |
Horton, JK; Srivastava, DK; Wilson, SH; Zmudzka, BZ | 1 |
Barnett, MJ; Fairey, RN; Hogge, DE; Klasa, RJ; Klingemann, HG; Nantel, SH; Reece, DE; Shepherd, JD; Sutherland, HJ; Voss, NJ | 1 |
Herrmann, JJ; Hurria, A; Kuzel, TM; Rademaker, AW; Roenigk, HH; Rosen, ST; Samuelson, E | 1 |
Buttin, G; De Saint Vincent, BR; Lunel-Orsini, C | 1 |
Brice, P; Castaigne, S; Gisselbrecht, C; Marolleau, JP; Pautier, P | 1 |
Aguirre, C; Calvo, R; Rodríguez-Sasiain, JM | 1 |
Greenstein, RJ | 1 |
Meller, JA; Ramsay, DL; Zackheim, HS | 1 |
Gazdar, AF; Ghosh, BC; Ihde, DC; Johnson, BE; Linnoila, RI; Minna, JD; Mulshine, JL; Oie, HK; Pass, HI; Phelps, R; Russell, EK; Shaw, GL; Steinberg, SM | 1 |
Carsuzaa, F; Richard-Lallemand, MA | 1 |
Bass, G; Bloxham, D; Gandhi, MK; Jestice, K; Marcus, RE; Scott, MA | 1 |
Devereux, S; Goldstone, AH; Gregory, W; Hancock, B; Harrison, CN; Hoskin, P; Hudson, GV; Linch, DC; MacMillan, AK; Milligan, D; Newland, AC; Winfield, D | 1 |
Ara, G; Bunnell, C; Elias, A; Frei, E; Richardson, P; Teicher, B; Tew, K; Wheeler, C | 1 |
Gellrich, S; Muche, JM; Sterry, W | 1 |
Avigdor, A; Ben-Bassat, I; Grotto, I; Hardan, I; Raanani, P; Shpilberg, O | 1 |
Duvic, M | 1 |
Muekusch, G; Pitman, J | 1 |
Estève, E; Grange, F | 1 |
García-Sanz, R; González-López, TJ; Graciani, IF; Hermida, G; San Miguel, JF; Vázquez, L | 1 |
Kuruvilla, J | 1 |
Nagai, H | 1 |
18 review(s) available for carmustine and mechlorethamine
Article | Year |
---|---|
[Treatment of relapses and failures in disseminated Hodgkin's disease].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow Transplantation; Carmustine; Cisplatin; Cyclophosphamide; Cytarabine; Dacarbazine; Doxorubicin; Epirubicin; Etoposide; Hodgkin Disease; Humans; Ifosfamide; Mechlorethamine; Melphalan; Methotrexate; Mitoguazone; Prednisone; Procarbazine; Remission Induction; Transplantation, Autologous; Transplantation, Homologous; Vinblastine; Vincristine | 1991 |
Treatment of cutaneous T-cell lymphoma.
Topics: Adjuvants, Immunologic; Administration, Topical; Carmustine; Combined Modality Therapy; Humans; Immunotherapy; Lymphoma; Mechlorethamine; PUVA Therapy; Skin; Skin Neoplasms; Ultraviolet Therapy | 1985 |
Combination chemotherapy of advanced Hodgkin's disease. A review.
Topics: Bleomycin; Carmustine; Cyclohexanes; Cyclophosphamide; Drug Evaluation; Drug Therapy, Combination; Hodgkin Disease; Italy; Mechlorethamine; Nitrosourea Compounds; Prednisone; Procarbazine; Remission, Spontaneous; United States; Vinblastine; Vincristine | 1974 |
The sensitivity of Hodgkin's disease to chemotherapeutic agents administered singly.
Topics: Adrenal Cortex Hormones; Alopecia; Antineoplastic Agents; Bleomycin; Blood Platelet Disorders; Carmustine; Chlorambucil; Cyclophosphamide; Daunorubicin; Drug Evaluation; Drug Therapy, Combination; Hodgkin Disease; Humans; Leukopenia; Mechlorethamine; Mitolactol; Nervous System Diseases; Procarbazine; Remission, Spontaneous; Streptonigrin; Vinblastine; Vincristine | 1973 |
[Cytostatic chemotherapy in lymphogranulomatosis].
Topics: Antineoplastic Agents; Bleomycin; Carmustine; Chlorambucil; Cyclohexanes; Cyclophosphamide; Doxorubicin; Drug Combinations; Hodgkin Disease; Humans; Mechlorethamine; Nitrosourea Compounds; Procarbazine; Prognosis; Splenectomy; Vinblastine; Vincristine | 1973 |
A review of chemotherapy in gastric cancer.
Topics: Adenocarcinoma; Antineoplastic Agents; Carmustine; Chlorambucil; Chromomycins; Cyclophosphamide; Cytarabine; Drug Evaluation; Drug Therapy, Combination; Floxuridine; Fluorouracil; Humans; Mechlorethamine; Methotrexate; Mitomycins; Nitrosourea Compounds; Olivomycins; Stomach Neoplasms | 1974 |
Single-agent therapy for Hodgkin's disease.
Topics: Alkylating Agents; Antibiotics, Antineoplastic; Antimetabolites; Antineoplastic Agents; Carmustine; Chlorambucil; Cyclophosphamide; Dactinomycin; Evaluation Studies as Topic; Fluorouracil; Hodgkin Disease; Humans; Mechlorethamine; Mercaptopurine; Methotrexate; Prednisone; Procarbazine; Thiotepa; Vinblastine; Vincristine | 1973 |
Combination chemotherapy in malignant diseases.
Topics: Adult; Antineoplastic Agents; Asparaginase; Carmustine; Child; Cyclophosphamide; Cytarabine; Cytosine; Daunorubicin; Drug Therapy, Combination; Hodgkin Disease; Humans; Immunotherapy; Leukemia, Lymphoid; Leukemia, Myeloid, Acute; Lymphoma; Male; Mechlorethamine; Mercaptopurine; Methotrexate; Nitrogen Mustard Compounds; Prednisolone; Prednisone; Procarbazine; Remission, Spontaneous; Vincristine | 1971 |
Glutathione metabolism as a determinant of therapeutic efficacy: a review.
Topics: Aminoacridines; Amsacrine; Animals; Antineoplastic Agents; Biological Transport; Carmustine; Cyclophosphamide; Cytochrome P-450 Enzyme System; Glutathione; Humans; Mechlorethamine; Melphalan; Mercaptopurine; Mice; Neoplasms; Neoplasms, Experimental | 1984 |
High-dose alkylating agent therapy: a review of clinical experiences.
Topics: Alkylating Agents; Busulfan; Carcinoma, Bronchogenic; Carmustine; Dose-Response Relationship, Drug; Female; Humans; Lung Neoplasms; Male; Mechlorethamine; Melphalan; Neoplasms; Ovarian Neoplasms; Testicular Neoplasms | 1984 |
Treatment of cutaneous T-cell lymphoma.
Topics: Carmustine; Combined Modality Therapy; Humans; Interferon-alpha; Lymphoma, T-Cell, Cutaneous; Mechlorethamine; Methotrexate; Prognosis; PUVA Therapy; Skin Neoplasms | 1994 |
Topical treatment of early cutaneous T-cell lymphoma.
Topics: Administration, Topical; Antineoplastic Agents, Alkylating; Carmustine; History, 20th Century; Humans; Lymphoma, T-Cell, Cutaneous; Mechlorethamine; Skin Neoplasms | 1995 |
[Mycosis fungoides].
Topics: Antineoplastic Agents; Carmustine; Drug Therapy, Combination; Humans; Mechlorethamine; Mycosis Fungoides; Neoplasm Staging; Phototherapy; Retinoids; Skin Neoplasms; Survival Analysis; Treatment Outcome | 1997 |
Cutaneous T cell lymphoma: update of treatment.
Topics: Administration, Topical; Adrenal Cortex Hormones; Antineoplastic Agents, Alkylating; Beta Particles; Carmustine; Humans; Interferon-alpha; Lymphoma, T-Cell, Cutaneous; Mechlorethamine; Methotrexate; PUVA Therapy; Retinoids; Skin Neoplasms; Treatment Outcome; Ultraviolet Rays | 1999 |
Treatment of cutaneous T-cell lymphomas.
Topics: Adjuvants, Immunologic; Administration, Topical; Antibodies, Monoclonal; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cancer Vaccines; Carmustine; Combined Modality Therapy; Glucocorticoids; Humans; Lymphoma, T-Cell, Cutaneous; Mechlorethamine; Phototherapy; Radiotherapy | 2000 |
Current treatment of Cutaneous T-Cell Lymphoma.
Topics: Administration, Oral; Administration, Topical; Anticarcinogenic Agents; Apoptosis; Bexarotene; Biopsy; Carmustine; Disease Progression; Drug Eruptions; Humans; Hypertriglyceridemia; Lymphoma, T-Cell, Cutaneous; Mechlorethamine; Neoplasm Staging; Prognosis; PUVA Therapy; Retinoids; Sezary Syndrome; Tetrahydronaphthalenes; Vitamin D | 2001 |
Standard therapy of advanced Hodgkin lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carmustine; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Dacarbazine; Dexamethasone; Disease-Free Survival; Doxorubicin; Etoposide; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Mechlorethamine; Melphalan; Methylprednisolone; Positron-Emission Tomography; Prednisone; Procarbazine; Radiotherapy, Adjuvant; Randomized Controlled Trials as Topic; Salvage Therapy; Transplantation, Autologous; Treatment Outcome; Vinblastine; Vincristine; Vindesine | 2009 |
[Treatment strategy of Hodgkin lymphoma].
Topics: Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Brentuximab Vedotin; Carmustine; Clinical Trials as Topic; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Dacarbazine; Dexamethasone; Doxorubicin; Etoposide; Hodgkin Disease; Humans; Immunoconjugates; Mechlorethamine; Melphalan; Molecular Targeted Therapy; Neoplasm Recurrence, Local; Positron-Emission Tomography; Prednisone; Procarbazine; Prognosis; Radiotherapy, Adjuvant; Rituximab; Vinblastine; Vincristine | 2014 |
12 trial(s) available for carmustine and mechlorethamine
Article | Year |
---|---|
Clinical trials with BCNU (NSC-409962) in malignant lymphomas by the Eastern Cooperative Oncology Group.
Topics: Bleomycin; Carmustine; Chlorambucil; Clinical Trials as Topic; Cyclophosphamide; Doxorubicin; Drug Therapy, Combination; Evaluation Studies as Topic; Humans; Lymphoma; Lymphoma, Large B-Cell, Diffuse; Mechlorethamine; Prednisone; Procarbazine; Prospective Studies; Vincristine | 1976 |
Multiple agent chemotherapy for advanced histiocytic lymphoma.
Topics: Adult; Aged; Bleomycin; Carmustine; Clinical Trials as Topic; Cyclophosphamide; Drug Therapy, Combination; Female; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Mechlorethamine; Middle Aged; Prednisone; Vincristine | 1976 |
A comparative study of a BCNU containing 4-drug program versus MOPP versus 3-drug combinations in advanced Hodgkin's disease: a cooperative study by the Cancer and Leukemia Group B.
Topics: Adult; Antineoplastic Agents; Carmustine; Clinical Trials as Topic; Drug Therapy, Combination; Female; Hodgkin Disease; Humans; Leukemia; Male; Mechlorethamine; Middle Aged; Neoplasms, Multiple Primary; Prednisone; Procarbazine; Remission, Spontaneous; Time Factors; Vincristine | 1979 |
Lymphosarcoma. A comparison of extended to conservative chemotherapy.
Topics: Adult; Aged; Carmustine; Chlorambucil; Cyclophosphamide; Drug Therapy, Combination; Female; Humans; Lymphoma, Non-Hodgkin; Male; Mechlorethamine; Middle Aged; Prednisone; Remission, Spontaneous; Vincristine | 1976 |
A prospective randomized study of two alternating, non cross-resistant chemotherapies for advanced Hodgkin's disease.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carmustine; Dacarbazine; Doxorubicin; Etoposide; Female; Hodgkin Disease; Humans; Male; Mechlorethamine; Mitoguazone; Prednisone; Procarbazine; Prospective Studies; Survival Rate; Vinblastine; Vincristine | 1992 |
Chemotherapy of Hodgkin's disease in studies by acute leukemia group B.
Topics: Antineoplastic Agents; Carmustine; Chlorambucil; Evaluation Studies as Topic; Hodgkin Disease; Humans; Mechlorethamine; Prednisone; Procarbazine; Vinblastine; Vincristine | 1973 |
BCVPP chemotherapy for advanced Hodgkin's disease: evidence for greater duration of complete remission, greater survival, and less toxicity than with a MOPP regimen. Results of the Eastern Cooperative Oncology Group study.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Blood Cell Count; Carmustine; Clinical Trials as Topic; Combined Modality Therapy; Cyclophosphamide; Female; Gastrointestinal Diseases; Hematologic Diseases; Hodgkin Disease; Humans; Male; Mechlorethamine; Neoplasm Staging; Peripheral Nervous System Diseases; Prednisone; Procarbazine; Random Allocation; Vinblastine; Vincristine | 1984 |
Acute myelogenous leukemia as a second malignant neoplasm following the successful treatment of advanced Hodgkin's disease.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cyclophosphamide; Female; Hodgkin Disease; Humans; Leukemia, Myeloid, Acute; Male; Mechlorethamine; Middle Aged; Neoplasms, Multiple Primary; Prednisone; Procarbazine; Risk; Vinblastine; Vincristine | 1983 |
Treatment of advanced Hodgkin's disease: 10-year experience in the Eastern Cooperative Oncology group.
Topics: Adult; Antineoplastic Agents; Carmustine; Clinical Trials as Topic; Cyclophosphamide; Drug Therapy, Combination; Female; Hodgkin Disease; Humans; Male; Mechlorethamine; Prednisone; Procarbazine; Vinblastine; Vincristine | 1982 |
Post-therapeutic acute malignant myeloproliferative syndrome and acute nonlymphocytic leukemia in non-Hodgkin's lymphoma.
Topics: Adult; Aged; Antineoplastic Agents; Carmustine; Cyclophosphamide; Drug Administration Schedule; Drug Therapy, Combination; Humans; Leukemia; Leukemia, Radiation-Induced; Lymphoma; Mechlorethamine; Middle Aged; Neoplasms; Neoplasms, Radiation-Induced; Radiotherapy; Syndrome; Vincristine | 1982 |
High-dose cyclophosphamide, carmustine (BCNU), and etoposide (VP16-213) with or without cisplatin (CBV +/- P) and autologous transplantation for patients with Hodgkin's disease who fail to enter a complete remission after combination chemotherapy.
Topics: Actuarial Analysis; Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow Diseases; Bone Marrow Transplantation; Carmustine; Cisplatin; Cyclophosphamide; Dacarbazine; Disease-Free Survival; Doxorubicin; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Leucovorin; Male; Mechlorethamine; Methotrexate; Prednisolone; Prednisone; Procarbazine; Remission Induction; Salvage Therapy; Survival Analysis; Treatment Outcome; Vinblastine; Vincristine | 1995 |
Correlation of in vitro drug sensitivity testing results with response to chemotherapy and survival: comparison of non-small cell lung cancer and small cell lung cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Carcinoma, Small Cell; Carmustine; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Etoposide; Evaluation Studies as Topic; Humans; Lomustine; Lung Neoplasms; Mechlorethamine; Methotrexate; Palliative Care; Predictive Value of Tests; Prospective Studies; Specimen Handling; Survival Analysis; Treatment Outcome; Tumor Cells, Cultured; Vincristine | 1996 |
64 other study(ies) available for carmustine and mechlorethamine
Article | Year |
---|---|
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics | 2010 |
Radiation and chemically induced potentially lethal lesions in noncycling mammalian cells: recovery analysis in terms of x-ray- and ultraviolet-like-systems.
Topics: Animals; Antineoplastic Agents; Bleomycin; Carmustine; Cell Line; Cell Survival; Cells, Cultured; DNA Repair; Dose-Response Relationship, Radiation; Doxorubicin; In Vitro Techniques; Mechlorethamine; Methyl Methanesulfonate; Radiation Genetics; Ultraviolet Rays; X-Rays | 1975 |
[Chemotherapy in bronchogenic carcinoma (author's transl)].
Topics: Antineoplastic Agents; Bleomycin; Carcinoma, Bronchogenic; Carmustine; Cyclophosphamide; Doxorubicin; Drug Therapy, Combination; Humans; Lomustine; Lung Neoplasms; Mechlorethamine; Methotrexate; Procarbazine; Vinblastine | 1977 |
Action of radiation or alkylating agents on LSA lymphoma during growth.
Topics: Alkylating Agents; Animals; Carmustine; Cell Survival; Cobalt Radioisotopes; Cyclophosphamide; Dose-Response Relationship, Drug; Dose-Response Relationship, Radiation; Kinetics; Lymphoma; Mechlorethamine; Mice; Mice, Inbred C57BL; Neoplasms, Experimental; Radiotherapy, High-Energy | 1979 |
DNA-protein cross-linking and DNA interstrand cross-linking by haloethylnitrosoureas in L1210 cells.
Topics: Animals; Carmustine; Cells, Cultured; Chemical Phenomena; Chemistry; DNA, Neoplasm; Endopeptidases; Leukemia L1210; Lomustine; Mechlorethamine; Neoplasm Proteins; Nitrosourea Compounds; Streptozocin | 1978 |
Ablation of murine jejunal crypts by alkylating agents.
Topics: Alkylating Agents; Animals; Carmustine; Cell Survival; Dose-Response Relationship, Drug; Jejunum; Male; Mechlorethamine; Mesylates; Mice | 1979 |
Topical chemotherapy of mycosis fungoides.
Topics: Administration, Topical; Carmustine; Humans; Mechlorethamine; Mycosis Fungoides; Skin Neoplasms | 1979 |
DNA damage and repair in mouse leukemia L1210 cells treated with nitrogen mustard, 1,3-bis(2-chloroethyl)-1-nitrosourea, and other nitrosoureas.
Topics: Animals; Carmustine; Cell Survival; Cells, Cultured; Chemical Phenomena; Chemistry; DNA Repair; DNA, Neoplasm; DNA, Single-Stranded; Leukemia L1210; Lomustine; Mechlorethamine; Methylnitrosourea; Neoplasm Proteins; Nitrosourea Compounds | 1977 |
Comparison of different methods of determining cell viability after exposure to cytotoxic compounds.
Topics: Amphotericin B; Antibiotics, Antineoplastic; Antineoplastic Agents; Carmustine; Cell Adhesion; Cell Line; Cell Survival; Chlorambucil; Cytarabine; Cytological Techniques; Doxorubicin; Mechlorethamine; Nogalamycin; Pactamycin; Tubercidin; Vincristine | 1976 |
Treatment of plasma cell myeloma with cytotoxic agents.
Topics: Acute Disease; Alkylating Agents; Bence Jones Protein; Bone Neoplasms; Carmustine; Cell Count; Cyclophosphamide; Drug Therapy, Combination; Humans; Immunoglobulin kappa-Chains; Immunoglobulin lambda-Chains; Mechlorethamine; Melphalan; Multiple Myeloma; Myeloma Proteins; Prednisone; Remission, Spontaneous; Time Factors | 1975 |
Study of in vivo tumor state and response to therapy by analysis of DNA distribution.
Topics: Animals; Carmustine; Cell Survival; Cobalt Radioisotopes; DNA, Neoplasm; Female; Hydroxyurea; Kinetics; Lymphoma; Mechlorethamine; Mice; Mice, Inbred C57BL; Neoplasms, Experimental; Radioisotope Teletherapy; Thymidine | 1976 |
Liposomal potentiation of the antitumor activity of alkylating drugs.
Topics: Alkylating Agents; Animals; Carcinoma, Ehrlich Tumor; Carmustine; Drug Synergism; Leukemia L1210; Liposomes; Mechlorethamine; Mice; Mice, Inbred DBA | 1976 |
The role of drug transport in resistance to nitrogen mustard and other alkylating agents in L518Y lymphoblsts.
Topics: Alkylating Agents; Animals; Binding, Competitive; Biological Transport; Carmustine; Cell Line; Chlorambucil; Cyclophosphamide; Dose-Response Relationship, Drug; Drug Resistance; Female; Leukemia, Experimental; Leukemia, Lymphoid; Male; Mechlorethamine; Melphalan; Mice; Mice, Inbred DBA; Mitomycins | 1975 |
1,3-bis(2-chloroethyl)-1-nitrosourea(BCNU), cyclophosphamide, vincristine- and prednisone-(BCOP). A new therapeutic regimen for diffuse histiocytic lymphoma.
Topics: Carmustine; Cyclophosphamide; Cytarabine; Drug Therapy, Combination; Humans; Lymphoma; Lymphoma, Large B-Cell, Diffuse; Mechlorethamine; Prednisone; Procarbazine; Remission, Spontaneous; Vincristine | 1975 |
Changes in sensitivity to cytotoxic agents occurring during the life history of monolayer cultures of a mouse tumour cell line.
Topics: Alkylating Agents; Animals; Antibiotics, Antineoplastic; Carmustine; Cell Division; Cell Line; Cell Survival; Dactinomycin; Dose-Response Relationship, Drug; Doxorubicin; Lomustine; Mechlorethamine; Mice; Neoplasms, Experimental | 1975 |
Treatment of mycosis fungoides with topical nitrosourea compounds: Further studies.
Topics: Administration, Topical; Adult; Aged; Bone Marrow; Carmustine; Cross Reactions; Drug Hypersensitivity; Female; Humans; Lomustine; Male; Mechlorethamine; Methylnitrosourea; Middle Aged; Mycosis Fungoides; Nitrosourea Compounds; Skin Neoplasms | 1975 |
Distinctive effects of mechlorethamine (NSC-762), cyclophosphamide (NSC-26271), and BCNU (NSC-409962) on transcription in Ehrlich cells.
Topics: Adenosine Triphosphate; Alkylating Agents; Animals; Carcinoma, Ehrlich Tumor; Carmustine; Cell Nucleus; Cyclophosphamide; In Vitro Techniques; Mechlorethamine; Mice; Nucleic Acid Precursors; Nucleotidyltransferases; Poly A; Polyribosomes; RNA, Messenger; RNA, Neoplasm; Transcription, Genetic | 1976 |
Heterogeneity in response to treatment with buthionine sulfoximine or interferon in human malignant glioma cells.
Topics: Buthionine Sulfoximine; Carmustine; Humans; In Vitro Techniques; Interferon-alpha; Mechlorethamine; Methionine Sulfoximine; Recombinant Proteins; Tumor Cells, Cultured | 1992 |
Glutathione levels and chemosensitizing effects of buthionine sulfoximine in human malignant glioma cells.
Topics: Adolescent; Adult; Aged; Antimetabolites, Antineoplastic; Brain Neoplasms; Buthionine Sulfoximine; Carmustine; Child; Drug Screening Assays, Antitumor; Drug Synergism; Female; Glioma; Glutathione; Humans; Male; Mechlorethamine; Methionine Sulfoximine; Middle Aged; Tumor Cells, Cultured | 1991 |
Allogeneic marrow transplantation for refractory Hodgkin's disease.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow Transplantation; Carmustine; Combined Modality Therapy; Cyclophosphamide; Dacarbazine; Doxorubicin; Etoposide; Female; Hodgkin Disease; Humans; Male; Mechlorethamine; Prednisone; Procarbazine; Remission Induction; Vinblastine; Vincristine | 1989 |
Combined modality therapy for mediastinal Hodgkin's disease. Prognostic significance of constitutional symptoms and size of disease.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carmustine; Combined Modality Therapy; Dacarbazine; Doxorubicin; Drug Resistance; Female; Hodgkin Disease; Humans; Male; Mechlorethamine; Mediastinal Neoplasms; Middle Aged; Prednisone; Procarbazine; Prognosis; Vinblastine; Vincristine | 1985 |
Mutational specificities of 1,3-bis(2-chloroethyl)-1-nitrosourea and nitrogen mustard in the SUP4-o gene of Saccharomyces cerevisiae.
Topics: Canavanine; Carmustine; Genes, Fungal; Mechlorethamine; Mutation; Saccharomyces cerevisiae | 1989 |
Glutathione and related enzymes in rat brain tumor cell resistance to 1,3-bis(2-chloroethyl)-1-nitrosourea and nitrogen mustard.
Topics: Animals; Brain Neoplasms; Buthionine Sulfoximine; Carmustine; Cell Line; Cell Survival; Chromatography, High Pressure Liquid; Clone Cells; Dinitrochlorobenzene; Drug Resistance; gamma-Glutamyltransferase; Glioma; Glutathione; Glutathione Transferase; Lomustine; Mechlorethamine; Methionine Sulfoximine; Rats; Semustine | 1987 |
Mutagenesis and repair of DNA damage caused by nitrogen mustard, N,N'-bis(2-chloroethyl)-N-nitrosourea (BCNU), streptozotocin, and mitomycin C in E. coli.
Topics: Carmustine; DNA Damage; DNA Glycosylases; DNA Repair; DNA, Bacterial; Escherichia coli; Genes, Bacterial; Mechlorethamine; Methyltransferases; Mitomycin; Mitomycins; N-Glycosyl Hydrolases; Rec A Recombinases; Site-Specific DNA-Methyltransferase (Adenine-Specific); SOS Response, Genetics; Streptozocin | 1986 |
The 'gastrointestinal syndrome' after chemotherapy: inferences from mouse survival time, and from histologically- and clonogenically-defined cell death in intestinal crypts.
Topics: Animals; Carmustine; Cell Survival; Cyclophosphamide; Dactinomycin; Doxorubicin; Fluorouracil; Jejunum; Male; Mechlorethamine; Mesylates; Mice | 1986 |
Cellular resistance to chloroethylnitrosoureas, nitrogen mustard, and cis-diamminedichloroplatinum(II) in human glial-derived cell lines.
Topics: Carmustine; Cell Line; Cell Survival; Cisplatin; DNA; Dose-Response Relationship, Drug; Drug Resistance; Glioma; Humans; Mechlorethamine; Methylation; Nimustine; Nitrosourea Compounds; Sister Chromatid Exchange | 1987 |
[Anticancer drug induced sister chromatid exchange and correlation to cell survival in human brain tumor cells].
Topics: Antineoplastic Agents; Brain Neoplasms; Carmustine; Cell Line; Cell Survival; Cisplatin; Glioma; Humans; Mechlorethamine; Nimustine; Nitrosourea Compounds; Sister Chromatid Exchange; Tumor Stem Cell Assay | 1987 |
Alkylating agent resistance: in vitro studies with human cell lines.
Topics: Alkylating Agents; Carmustine; Cell Line; Cell Survival; Cisplatin; Drug Resistance; Glutathione; Humans; Mechlorethamine | 1985 |
International Symposium on Hodgkin's Disease. Session 4. Small group workshops. Report on workshop: Chemotherapy.
Topics: Antineoplastic Agents; Bleomycin; Carmustine; Doxorubicin; Drug Therapy, Combination; Hodgkin Disease; Humans; Leukemia; Mechlorethamine; Nitrosourea Compounds; Prednisone; Procarbazine; Remission, Spontaneous; Time Factors; Vincristine | 1973 |
Acute leukemia in Hodgkin's disease.
Topics: Adult; Bleomycin; Carmustine; Chlorambucil; Drug Therapy, Combination; Female; Hodgkin Disease; Humans; Leukemia, Myeloid, Acute; Male; Mechlorethamine; Middle Aged; Neoplasms, Multiple Primary; Prednisone; Procarbazine; Time Factors; Vinblastine | 1974 |
Prognosis and survival with extranodal Hodgkin's disease.
Topics: Adult; Carmustine; Chlorambucil; Cyclophosphamide; Drug Therapy, Combination; Hodgkin Disease; Humans; Mechlorethamine; Palliative Care; Prednisone; Procarbazine; Prognosis; Recurrence; Retrospective Studies; Time Factors; Vinblastine; Vinca Alkaloids; Vincristine | 1974 |
A comparison of the effects of alkylating agents 1,3-bis(2-chloroethyl)-1-nitrosourea, 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea and nitrogen mustard on nuclear RNA synthesis and processing.
Topics: Adenosine; Alkylating Agents; Carmustine; Cell Nucleolus; Cell Nucleus; Chromatography, Affinity; Cytoplasm; Electrophoresis, Polyacrylamide Gel; HeLa Cells; Humans; Macromolecular Substances; Mechlorethamine; Nitrosourea Compounds; Pancreas; Ribonucleases; RNA; RNA, Messenger; RNA, Neoplasm; RNA, Ribosomal; Tritium; Uridine | 1974 |
Comparative chemotherapy of AKR lymphoma and human hematological neoplasia.
Topics: Animals; Antineoplastic Agents; Biological Assay; Carmustine; Cyclohexanes; Cyclophosphamide; Cytarabine; Daunorubicin; Disease Models, Animal; Drug Therapy, Combination; Evaluation Studies as Topic; Female; Fluorouracil; Hodgkin Disease; Humans; Leukemia; Leukemia L1210; Leukemia, Experimental; Leukemia, Lymphoid; Leukemia, Myeloid, Acute; Lymphoma; Male; Mechlorethamine; Melphalan; Mice; Mice, Inbred AKR; Multiple Myeloma; Nitrosourea Compounds; Prednisone; Remission, Spontaneous; Vinblastine; Vincristine | 1974 |
Influence of chemotherapeutic agents on the antibacterial activity of normal and leukemic sera.
Topics: Antineoplastic Agents; Blood Bactericidal Activity; Carmustine; Cell Membrane; Complement System Proteins; Cyclophosphamide; Cytarabine; Daunorubicin; Dose-Response Relationship, Drug; Escherichia coli; Fluorouracil; Humans; Immunoglobulins; Leukemia; Mechlorethamine; Methotrexate; Microbial Sensitivity Tests; Muramidase; Prednisone; Vincristine | 1974 |
Eastern cooperative oncology group studies.
Topics: Antineoplastic Agents; Blood Cell Count; Carmustine; Cyclophosphamide; Hodgkin Disease; Humans; Mechlorethamine; Prednisone; Procarbazine; Remission, Spontaneous; Vinblastine | 1973 |
Updated Hodgkin's disease. C. Advanced disease and special problems. Management with combination therapy.
Topics: Antineoplastic Agents; Benzoates; Carmustine; Hodgkin Disease; Humans; Mechlorethamine; Prednisone; Procarbazine; Vincristine | 1973 |
Combined drug treatment of Hodgkin's disease: remission induction, remission duration, and survival; an appraisal.
Topics: Adult; Age Factors; Antineoplastic Agents; Biopsy; Carmustine; Chlorambucil; Cyclophosphamide; Dactinomycin; Drug Therapy, Combination; Evaluation Studies as Topic; Follow-Up Studies; Hodgkin Disease; Humans; Mechlorethamine; Middle Aged; Prednisone; Procarbazine; Remission, Spontaneous; Time Factors; Vinblastine; Vincristine | 1973 |
The action of hydroxyurea, 2,3 bis(2-chloroethyl)-1-nitrosourea (BCNU) and nitrogen mustard on glucose and water absorption from the small intestine of the rat.
Topics: Animals; Carmustine; Depression, Chemical; Glucose; Hydroxyurea; In Vitro Techniques; Intestinal Absorption; Intestine, Small; Mechlorethamine; Organ Size; Rats; Time Factors; Water | 1973 |
Liposomes as active participants in experimental therapeutics.
Topics: Animals; Antineoplastic Agents; Carmustine; Guanylyl Imidodiphosphate; Guinea Pigs; Liposomes; Mechlorethamine; Rats | 1984 |
Death of intestinal crypts and of their constituent cells after treatment by chemotherapeutic drugs.
Topics: Animals; Antineoplastic Agents; Carmustine; Cell Survival; Cyclophosphamide; Dactinomycin; Doxorubicin; Fluorouracil; Intestinal Mucosa; Jejunum; Male; Mechlorethamine; Mice; Necrosis | 1984 |
Treatment of advanced malignant melanoma with high-dose chemotherapy and autologous bone marrow transplantation. Preliminary results--Phase I study.
Topics: Adolescent; Adult; Antineoplastic Agents; Bone Marrow Transplantation; Brain Neoplasms; Carmustine; Cell Survival; Colony-Forming Units Assay; Drug Evaluation; Drug Therapy, Combination; Female; Humans; Lymphatic Metastasis; Male; Mechlorethamine; Melanoma; Melphalan; Middle Aged; Transplantation, Autologous | 1982 |
Prolonged topical maintenance therapy for mycosis fungoides.
Topics: Animals; Carmustine; Humans; Mechlorethamine; Mice; Mycosis Fungoides; Skin Neoplasms | 1983 |
Potentiation of anticancer agents by amphotericin B.
Topics: Amphotericin B; Animals; Antineoplastic Agents; Carmustine; Cell Survival; Colony-Forming Units Assay; Cyclophosphamide; Drug Synergism; Female; Leukemia, Experimental; Mechlorethamine; Mice; Mice, Inbred AKR; Vincristine | 1981 |
Effects of alkylating agents on the DNA replication of cultured Yoshida sarcoma cells.
Topics: Alkylating Agents; Animals; Carmustine; Cell Division; Cell Survival; Chlorambucil; Cyclophosphamide; DNA Replication; Doxorubicin; Kinetics; Mechlorethamine; Melphalan; Mice; Sarcoma, Yoshida; Structure-Activity Relationship | 1982 |
Differential enhancement of antitumor effectiveness by phospholipid vesicles (liposomes).
Topics: Animals; Biological Transport, Active; Carcinoma, Ehrlich Tumor; Carmustine; Cell Line; Cell Membrane; Cell Membrane Permeability; Leukemia L1210; Liposomes; Mechlorethamine; Mice; Microscopy, Electron; Neoplasm Transplantation; Prognosis; Time Factors | 1981 |
Radiation sensitivity modification by chemotherapeutic agents.
Topics: Animals; Antineoplastic Agents; Carmustine; Chlorambucil; Cricetinae; Cricetulus; Fibroblasts; Mechlorethamine; Radiation-Sensitizing Agents; Time Factors | 1981 |
Tumorigenic effect of topical mechlorethamine, BCNU and CCNU in mice.
Topics: Animals; Carcinogens; Carcinoma, Squamous Cell; Carmustine; Lomustine; Mechlorethamine; Mice; Neoplasms, Experimental; Nitrosourea Compounds; Papilloma; Skin Neoplasms | 1980 |
DNA damage in rat 9L cells treated with nitrogen mustard and 1,3-bis(2-chloroethyl)-1-nitrosourea assayed by viscoelastometry and S1 nuclease.
Topics: Animals; Brain Neoplasms; Carmustine; Cell Line; Cross-Linking Reagents; Deoxyribonucleases; DNA, Neoplasm; DNA, Single-Stranded; Elasticity; Gamma Rays; Interphase; Mechlorethamine; Methods; Neoplasms, Experimental; Nucleic Acid Denaturation; Rats; Viscosity | 1980 |
Peritoneal exudate mononuclear phagocyte colony-forming cells: their proliferative state in vivo and sensitivity to cytotoxic agents.
Topics: Animals; Ascitic Fluid; Autoradiography; Carmustine; Cell Division; Colony-Forming Units Assay; Cyclophosphamide; Cytarabine; Female; Hematopoietic Stem Cells; Macrophages; Male; Mechlorethamine; Methotrexate; Mice; Mice, Inbred C3H; Thymidine; Tritium; Vinblastine | 1980 |
The response of EMT6 tumor spheroids to combined treatment with misonidazole and either nitrogen mustard, adriamycin, or BCNU.
Topics: Animals; Antineoplastic Agents; Carmustine; Cell Survival; Dose-Response Relationship, Drug; Doxorubicin; In Vitro Techniques; Mammary Neoplasms, Experimental; Mechlorethamine; Mice; Misonidazole; Nitroimidazoles; Radiation-Sensitizing Agents | 1980 |
Strategic down-regulation of DNA polymerase beta by antisense RNA sensitizes mammalian cells to specific DNA damaging agents.
Topics: 3T3 Cells; Animals; Antineoplastic Agents; Bleomycin; Carmustine; Cell Death; Cisplatin; DNA; DNA Damage; DNA Polymerase I; Gene Expression Regulation; Humans; Mechlorethamine; Melphalan; Methyl Methanesulfonate; Mice; RNA, Antisense; Transfection; Ultraviolet Rays; Zinc | 1995 |
Treatment of mycosis fungoides with photochemotherapy (PUVA): long-term follow-up.
Topics: Biopsy; Carmustine; Cohort Studies; Female; Follow-Up Studies; Humans; Male; Mechlorethamine; Middle Aged; Mycosis Fungoides; Neoplasm Recurrence, Local; PUVA Therapy; Skin; Skin Neoplasms; Survival Rate; Time Factors; Treatment Outcome | 1995 |
A glutathione depletion selectively imposed on mu glutathione S-transferase overproducing cells increases nitrogen mustard toxicity.
Topics: Animals; Buthionine Sulfoximine; Carmustine; Cell Line; Cell Survival; Cisplatin; Cricetinae; Cricetulus; Doxorubicin; Glutathione; Glutathione Transferase; Inactivation, Metabolic; Mechlorethamine; Methionine Sulfoximine | 1995 |
Pregnancy after autologous bone marrow transplantation for malignant lymphomas.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cyclophosphamide; Cytarabine; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Infant, Newborn; Lymphoma, Large B-Cell, Diffuse; Mechlorethamine; Melphalan; Podophyllotoxin; Prednisone; Pregnancy; Pregnancy Outcome; Procarbazine; Remission Induction; Salvage Therapy; Vincristine | 1994 |
Decrease in penbutolol protein binding as a consequence of treatment with some alkylating agents.
Topics: Adult; Alkylating Agents; Blood Proteins; Carmustine; Dialysis; Drug Interactions; Female; Humans; Male; Mechlorethamine; Penbutolol; Protein Binding | 1994 |
Age, as well as cell turnover kinetics, regulates brain/gut repair.
Topics: Aging; Animals; Brain; Carmustine; Cell Cycle; Cholecystokinin; DNA; DNA Damage; Intestinal Mucosa; Intestines; Mechlorethamine; Radioimmunoassay; Rats; Rats, Sprague-Dawley; RNA, Messenger | 1993 |
The minimum CD34 threshold depends on prior chemotherapy in autologous peripheral blood stem cell recipients.
Topics: Adolescent; Adult; Antigens, CD34; Antineoplastic Combined Chemotherapy Protocols; Blood Cell Count; Carmustine; Combined Modality Therapy; Female; Hematologic Neoplasms; Hematopoietic Stem Cell Mobilization; Hematopoietic Stem Cell Transplantation; Hematopoietic Stem Cells; Humans; Lomustine; Male; Mechlorethamine; Melphalan; Middle Aged; Transplantation, Autologous | 1999 |
High-dose BEAM chemotherapy with autologous haemopoietic stem cell transplantation for Hodgkin's disease is unlikely to be associated with a major increased risk of secondary MDS/AML.
Topics: Acute Disease; Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Child; Child, Preschool; Chlorambucil; Cohort Studies; Combined Modality Therapy; Cytarabine; Doxorubicin; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Incidence; Infant; Leukemia, Myeloid; Life Tables; Lomustine; Male; Mechlorethamine; Melphalan; Middle Aged; Myelodysplastic Syndromes; Neoplasms, Second Primary; Podophyllotoxin; Prednisolone; Prednisone; Procarbazine; Retrospective Studies; Risk; Salvage Therapy; Vinblastine; Vincristine | 1999 |
Double high-dose chemotherapy with stem cell rescue (HD-SCR) in patients with breast cancer - effect of sequence.
Topics: Alkylating Agents; Animals; Antineoplastic Agents; Breast Neoplasms; Carmustine; Cell Survival; Cisplatin; Cyclophosphamide; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Female; Hematopoietic Stem Cell Transplantation; Humans; Mechlorethamine; Melphalan; Mice; Neoplasms, Experimental; Tumor Cells, Cultured | 2000 |
[High-dose chemotherapy and autologous stem cell transplantation for refractory and relapsing Hodgkin's disease as first-line therapy-- studies at Sheba Medical Center--Tel Hashomer].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carmustine; Combined Modality Therapy; Cytarabine; Dacarbazine; Doxorubicin; Female; Follow-Up Studies; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Male; Mechlorethamine; Melphalan; Middle Aged; Podophyllotoxin; Prednisone; Procarbazine; Recurrence; Retrospective Studies; Survival Rate; Time Factors; Vinblastine; Vincristine | 2000 |
Mycosis fungoides.
Topics: Anti-Inflammatory Agents; Antineoplastic Agents, Alkylating; Carmustine; Causality; Humans; Mechlorethamine; Mycosis Fungoides; Patient Education as Topic; PUVA Therapy; Skin Care; Skin Neoplasms | 2007 |
[Chlormethine (Caryolysine), carmustine (Bicnu)].
Topics: Antineoplastic Agents, Alkylating; Carmustine; Humans; Mechlorethamine; Skin Neoplasms | 2007 |
The combination of thalidomide, cyclophosphamide and dexamethasone is potentially useful in highly resistant Hodgkin's lymphoma.
Topics: Adult; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carmustine; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Dacarbazine; Deoxycytidine; Dexamethasone; Doxorubicin; Drug Resistance, Neoplasm; Etoposide; Hodgkin Disease; Humans; Male; Mechlorethamine; Melphalan; Organoplatinum Compounds; Paclitaxel; Peripheral Blood Stem Cell Transplantation; Prednisolone; Prednisone; Procarbazine; Remission Induction; Rituximab; Salvage Therapy; Thalidomide; Topotecan; Transplantation, Autologous; Vidarabine; Vinblastine; Vincristine | 2010 |